Enhanced Collagen Deposition in the Duodenum of Patients with Hyaline Fibromatosis Syndrome and Protein Losing Enteropathy
- PMID: 33147779
- PMCID: PMC7662532
- DOI: 10.3390/ijms21218200
Enhanced Collagen Deposition in the Duodenum of Patients with Hyaline Fibromatosis Syndrome and Protein Losing Enteropathy
Abstract
Hyaline fibromatosis syndrome (HFS), resulting from ANTXR2 mutations, is an ultra-rare disease that causes intestinal lymphangiectasia and protein-losing enteropathy (PLE). The mechanisms leading to the gastrointestinal phenotype in these patients are not well defined. We present two patients with congenital diarrhea, severe PLE and unique clinical features resulting from deleterious ANTXR2 mutations. Intestinal organoids were generated from one of the patients, along with CRISPR-Cas9 ANTXR2 knockout, and compared with organoids from two healthy controls. The ANTXR2-deficient organoids displayed normal growth and polarity, compared to controls. Using an anthrax-toxin assay we showed that the c.155C>T mutation causes loss-of-function of ANTXR2 protein. An intrinsic defect of monolayer formation in patient-derived or ANTXR2KO organoids was not apparent, suggesting normal epithelial function. However, electron microscopy and second harmonic generation imaging showed abnormal collagen deposition in duodenal samples of these patients. Specifically, collagen VI, which is known to bind ANTXR2, was highly expressed in the duodenum of these patients. In conclusion, despite resistance to anthrax-toxin, epithelial cell function, and specifically monolayer formation, is intact in patients with HFS. Nevertheless, loss of ANTXR2-mediated signaling leads to collagen VI accumulation in the duodenum and abnormal extracellular matrix composition, which likely plays a role in development of PLE.
Keywords: ANTXR2; CMG2; extracellular matrix; intestinal lymphangiectasia; organoids; protein losing enteropathy.
Conflict of interest statement
The authors declare no conflict of interest.
Figures






References
-
- Burgi J., Kunz B., Abrami L., Deuquet J., Piersigilli A., Scholl-Burgi S., Lausch E., Unger S., Superti-Furga A., Bonaldo P., et al. CMG2/ANTXR2 regulates extracellular collagen VI which accumulates in hyaline fibromatosis syndrome. Nat. Commun. 2017;8:15861. doi: 10.1038/ncomms15861. - DOI - PMC - PubMed
-
- Tanaka K., Ebihara T., Kusubata M., Adachi E., Arai M., Kawaguchi N., Utsunomiya J., Miki Y., Hiramoto M., Hattori S., et al. Abnormal collagen deposition in fibromas from patient with juvenile hyaline fibromatosis. J. Dermatol. Sci. 2009;55:197–200. doi: 10.1016/j.jdermsci.2009.06.005. - DOI - PubMed
-
- Dowling O., Difeo A., Ramirez M.C., Tukel T., Narla G., Bonafe L., Kayserili H., Yuksel-Apak M., Paller A.S., Norton K., et al. Mutations in capillary morphogenesis gene-2 result in the allelic disorders juvenile hyaline fibromatosis and infantile systemic hyalinosis. Am. J. Hum. Genet. 2003;73:957–966. doi: 10.1086/378781. - DOI - PMC - PubMed
-
- Hanks S., Adams S., Douglas J., Arbour L., Atherton D.J., Balci S., Bode H., Campbell M.E., Feingold M., Keser G., et al. Mutations in the gene encoding capillary morphogenesis protein 2 cause juvenile hyaline fibromatosis and infantile systemic hyalinosis. Am. J. Hum. Genet. 2003;73:791–800. doi: 10.1086/378418. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials